Composition

Vaccine contains two components with an equal amount of doses:

• Suspension of inactivated agent of rabbit Hemorrhagic Disease, strain BG-04 from 640 to 1280 HAU in one dose, as a solvent for freeze-dried tablet;

• Freeze-dried tablet of vaccine virus of Myxomatosis, strain MAV/RK – 13/20 ≥ 10^4,0 EID₅₀ in one dose.

Pharmaceutical form

Freeze-dried tablet and suspension.

Immunological properties

Vaccine protects rabbits from Hemorrhagic Disease and Myxomatosis during 8-10 months, induces formation of protective antibodies in 7-14 days after vaccination.

Indications

Preventative immunization of rabbits against Hemorrhagic Disease and Myxomatosis.

Interaction with other preparations

Do not mix with other preparations, with components of other vaccines against rabbit disease and components of other batches of LAPIMUN GEMIX vaccine. Dehelmintization of rabbits is to be performed 2 weeks prior to or 2 weeks after vaccination.

Special precautions (during gestation period)

It is not recommended to vaccinate females 7 days before the parturition, because of "mechanical" abortions that may occur due to animals’ stresses.

Route of administration and dosage

The vaccine component, in the form of a suspension, is transferred to a vial containing the lyophilized component after shaking with a syringe. After dissolution, the vaccine is administered to clinically healthy rabbits, starting at 28 days of age, subcutaneously behind the shoulder blade at a dose of 1.0 ml, with revaccination at 4 months of age.

If there is a threat of early infection, all rabbits that have reached 28 days of age and older are vaccinated regardless of the timing of the previous vaccination, with a repeat vaccination after three months with the vaccine LAPIMUN GEMIX-3 or LAPIMUN MIX, a live vaccine against rabbit myxomatosis.

Rabbits are revaccinated every 8 months.

Vaccinated animals from the parent herd, when used intensively, are recommended to be revaccinated at 6-month intervals.

Withdrawal period

0 days.

Self life

18 months. Vaccine should be used within 3 hours after dissolving.

Storage conditions

Store vaccine in dry, dark places, out of the reach of children, at +2 to +8° С. Do not freeze!